New combined treatment improves heart function in CTEPH cases

New Combined Treatment Improves Heart Function in CTEPH Cases

A new sequential strategy successfully treats people with severe chronic thromboembolic pulmonary hypertension (CTEPH), significantly reducing high blood pressure and improving heart function, a study finds.

The three-step regimen consists of medication, followed by balloon pulmonary angioplasty (BPA), and pulmonary endarterectomy (PEA) surgery. This approach is designed for individuals facing unacceptably high surgical risk and complex blood clot locations.

When followed, this regimen significantly reduced blood pressure in the pulmonary arteries and a marker of heart failure, improved functionality, and led to a 95% survival rate, the data showed.

A study by Steve Bryson, PhD, found that this new strategy is effective in treating CTEPH.

Author's summary: New treatment improves heart function in CTEPH cases with 95% survival rate.

more

Pulmonary Hypertension News Pulmonary Hypertension News — 2025-10-13

More News